Cite
APA Citation
Gibb, A., Pirrie, S., Linton, K., Paterson, K., Davies, A., Collins, G., Menne, T., McKay, P., Fields, P., Miall, F., Nagy, E., Wheatley, K., Warbey, V., Barrington, S., & Radford, J. (n.d.). rESULTS OF a PHASE II STUDY OF BRENTUXIMAB VEDOTIN IN THE FIRST LINE TREATMENT OF HODGKIN LYMPHOMA PATIENTS CONSIDERED UNSUITABLE FOR STANDARD CHEMOTHERAPY (BREVITY). Hematological oncology, 35, 80–81. http://access.bl.uk/ark:/81055/vdc_100047525806.0x000036